Introduction
tumor, leukemia, AML, toxicities, ’ comorbidities
LEUKEMIA, ACUTE MYELOID LEUKEMIA, AML, TUMOR
The prognosis of elderly patients with acute myeloid leukemia (AML) is poor because of leukemia characteristics, patients’ comorbidities, and treatment toxicities [The OCV-501, a tumor vaccine, is an HLA class II-binding polypeptide consisting of 16 amino acid residues derived from WT1 protein [